119 related articles for article (PubMed ID: 23615426)
1. The protective effects of β-cryptoxanthin on inflammatory bone resorption in a mouse experimental model of periodontitis.
Matsumoto C; Ashida N; Yokoyama S; Tominari T; Hirata M; Ogawa K; Sugiura M; Yano M; Inada M; Miyaura C
Biosci Biotechnol Biochem; 2013; 77(4):860-2. PubMed ID: 23615426
[TBL] [Abstract][Full Text] [Related]
2. Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis.
Tominari T; Hirata M; Matsumoto C; Inada M; Miyaura C
J Pharmacol Sci; 2012; 119(4):390-4. PubMed ID: 22850615
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory, anti-osteoclastic, and antioxidant activities of genistein protect against alveolar bone loss and periodontal tissue degradation in a mouse model of periodontitis.
Bhattarai G; Poudel SB; Kook SH; Lee JC
J Biomed Mater Res A; 2017 Sep; 105(9):2510-2521. PubMed ID: 28509410
[TBL] [Abstract][Full Text] [Related]
5. Peptides from rice endosperm protein restrain periodontal bone loss in mouse model of periodontitis.
Tamura H; Maekawa T; Domon H; Hiyoshi T; Yonezawa D; Nagai K; Ochiai A; Taniguchi M; Tabeta K; Maeda T; Terao Y
Arch Oral Biol; 2019 Feb; 98():132-139. PubMed ID: 30485826
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts.
Kwak HB; Sun HM; Ha H; Kim HN; Lee JH; Kim HH; Shin HI; Lee ZH
Eur J Pharmacol; 2008 Dec; 601(1-3):30-7. PubMed ID: 18973753
[TBL] [Abstract][Full Text] [Related]
7. β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells.
Nishigaki M; Yamamoto T; Ichioka H; Honjo K; Yamamoto K; Oseko F; Kita M; Mazda O; Kanamura N
Arch Oral Biol; 2013 Jul; 58(7):880-6. PubMed ID: 23452546
[TBL] [Abstract][Full Text] [Related]
8. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
[TBL] [Abstract][Full Text] [Related]
10. Role of carotenoid β-cryptoxanthin in bone homeostasis.
Yamaguchi M
J Biomed Sci; 2012 Apr; 19(1):36. PubMed ID: 22471523
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
12. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
Koide M; Kinugawa S; Ninomiya T; Mizoguchi T; Yamashita T; Maeda K; Yasuda H; Kobayashi Y; Nakamura H; Takahashi N; Udagawa N
J Bone Miner Res; 2009 Aug; 24(8):1469-80. PubMed ID: 19292614
[TBL] [Abstract][Full Text] [Related]
13. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.
Curylofo-Zotti FA; Elburki MS; Oliveira PA; Cerri PS; Santos LA; Lee HM; Johnson F; Golub LM; Rossa C; Guimarães-Stabili MR
Arch Oral Biol; 2018 Jul; 91():42-50. PubMed ID: 29669267
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
16. Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.
Cetinkaya BO; Keles GC; Ayas B; Gurgor P
J Periodontol; 2008 Oct; 79(10):1950-61. PubMed ID: 18834251
[TBL] [Abstract][Full Text] [Related]
17. Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts.
Tominari T; Sanada A; Ichimaru R; Matsumoto C; Hirata M; Itoh Y; Numabe Y; Miyaura C; Inada M
Sci Rep; 2021 Jun; 11(1):13353. PubMed ID: 34172796
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 heterodimers, TLR2/6 and TLR2/1 induce prostaglandin E production by osteoblasts, osteoclast formation and inflammatory periodontitis.
Matsumoto C; Oda T; Yokoyama S; Tominari T; Hirata M; Miyaura C; Inada M
Biochem Biophys Res Commun; 2012 Nov; 428(1):110-5. PubMed ID: 23063683
[TBL] [Abstract][Full Text] [Related]
20. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation.
Liu R; Bal HS; Desta T; Krothapalli N; Alyassi M; Luan Q; Graves DT
J Dent Res; 2006 Jun; 85(6):510-4. PubMed ID: 16723646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
